Knowing the difference between a heart attack and a cardiac arrest could save a life. Do you know which one is which?

The term itself is a misnomer because CPR is for someone in cardiac arrest, meaning the heart has stopped beating. At that ...

An annual CAPA Membership provides a front row seat to global aviation news, analysis and data as it happens, with access to a comprehensive suite of tools that can be customised to your needs. Join ...

Fintel reports that on January 8, 2025, Canaccord Genuity downgraded their outlook for Accolade (NasdaqGS:ACCD) from Buy to Hold. Analyst Price Forecast Suggests 6.67% Upside As of December 23 ...

Fintel reports that on January 8, 2025, Needham downgraded their outlook for Accolade (NasdaqGS:ACCD) from Buy to Hold. Analyst Price Forecast Suggests 6.67% Upside As of December 23, 2024 ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on MoonLake Immunotherapeutics (MLTX – Research Report) and Accolade (ACCD – Research Report).

Wells Fargo analyst Stan Berenshteyn maintained a Hold rating on Accolade (ACCD – Research Report) yesterday and set a price target of $7.00. The company’s shares closed yesterday at $6.86.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Needham has recently reiterated Accolade Inc (ACCD) stock to Buy rating, as announced on June 28, 2024, according to Finviz. Earlier, on February 26, 2024, Leerink Partners had initiated the stock to ...

SEATTLE (AP) — Accolade, Inc. ACCD) on Friday reported a loss of $121.3 million in its fiscal third quarter. On a per-share basis, the Seattle-based company said it had a loss of $1.50.

Transcarent and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total ...